Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung and Liver Disease”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableStudy completedNCT00001885
What this trial is testing

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Who this might be right for
HealthyPulmonary FibrosisRheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI) 400
Not applicableStudy completedNCT03516994
What this trial is testing

Reducing Disparities in the Quality of Advance Care Planning for Older Adults

Who this might be right for
Metastatic CancerCongestive Heart FailureChronic Obstructive Pulmonary Disease+6 more
Duke University 790
Not applicableStudy completedNCT01615484
What this trial is testing

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis+5 more
University of North Carolina, Chapel Hill 24
Testing effectiveness (Phase 2)Study completedNCT01441037
What this trial is testing

Danazol for Genetic Bone Marrow and Lung Disorders

Who this might be right for
Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 27
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Not applicableEnded earlyNCT01241942
What this trial is testing

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis+5 more
University of North Carolina, Chapel Hill 11
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Not applicableWithdrawnNCT05514470
What this trial is testing

Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress

Who this might be right for
Interstitial Lung and Liver DiseaseInfantile Liver Failure Syndrome 1Neurologic, Endocrine and Pancreatic Disease, Multisystem, Infantile-Onset 2+1 more
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)Study completedNCT05180162
What this trial is testing

Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

Who this might be right for
Liver FibrosisPulmonary FibrosisMyocardial Fibrosis
Thomas Hope 16
Not applicableStudy completedNCT04283994
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 756
Testing effectiveness (Phase 2)Looking for participantsNCT03312400
What this trial is testing

Low-Dose Danazol for the Treatment of Telomere Related Diseases

Who this might be right for
Telomere Disease
National Heart, Lung, and Blood Institute (NHLBI) 40
Not applicableLooking for participantsNCT00001532
What this trial is testing

Role of Genetic Factors in the Development of Lung Disease

Who this might be right for
Cystic FibrosisPulmonary FibrosisTuberous Sclerosis+2 more
National Heart, Lung, and Blood Institute (NHLBI) 3,500
Not applicableEnrolling By InvitationNCT05001009
What this trial is testing

Goals of Care Conversations Study

Who this might be right for
Seriously Ill PatientsCancerHeart Failure+5 more
VA Office of Research and Development 72
Post-approval studies (Phase 4)Study completedNCT02858180
What this trial is testing

Hepatitis C Virus(HCV) Heart and Lung Study

Who this might be right for
Hepatitis C, ChronicHeart FailurePulmonary Disease, Chronic Obstructive+1 more
Duke University 15
Not applicableStudy completedNCT01476995
What this trial is testing

Prognostic Indicators as Provided by the EPIC ClearView

Who this might be right for
Coronary Artery DiseaseCongestive Heart FailureValvular Heart Disease+25 more
Epic Research & Diagnostics, Inc. 353
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Not applicableLooking for participantsNCT07301892
What this trial is testing

Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis

Who this might be right for
Rheumatoid Arthritis (RAOsteoporosisOsteoarthritis+12 more
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 100
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Load More Results